BOT 2.63% 37.0¢ botanix pharmaceuticals ltd

Ann: FDA Mid-Cycle Review Meeting Successfully Completed, page-32

  1. 324 Posts.
    lightbulb Created with Sketch. 91
    Shifting gears away from the cap raise chat. This remains a great step forward for BOT. Combined with a strong cash position and a register with increasingly stronger hands, the time appears nigh. The next 5 months will present a buying opportunity. If any placement holders puke in the short term for the 1c, I’ll be buying some. I sense however that puking is unlikely and we grind higher.
    Last edited by same1: 06/04/23
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
37.0¢
Change
-0.010(2.63%)
Mkt cap ! $669.7M
Open High Low Value Volume
38.0¢ 38.5¢ 36.5¢ $2.548M 6.766M

Buyers (Bids)

No. Vol. Price($)
2 96148 36.5¢
 

Sellers (Offers)

Price($) Vol. No.
37.0¢ 782479 9
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.